Up to 60% off Profit Pro - Limited Time Offer!
Winter Sale

60% off Profit Pro - Limited Time Offer!

Io

Iovance Biotherapeutics Inc.

0JDK ยท LSE
0JDK ยท LSE
7.50
USD0.060.82%

Day Range

7.26USD
7.50USD

52 Week Range

6.77USD
18.31USD

Market Cap

98.31BUSD

About

General Information

Type

Common Stock

Exchange

LSE

Currency Code

USD

Currency Name

US Dollar

Country Name

UK

Country ISO

GB

ISIN

-

CUSIP

-

Sector

Industry

Fiscal Year End

December

IPO date

-

Updated At

-

Highlights

PE Ratio

-

PEG Ratio

-

Book Value

2.54

Dividend Share

-

Dividend Yield

-

Earnings Share

-2.3

Wall Street Target Price

-

EPS Estimate Current Year

0

EPS Estimate Next Year

0

EPS Estimate Current Quarter

0

EPS Estimate Next Quarter

0

Most Recent Quarter

-

Profitability

Revenue TTM

90,858,000

Gross Profit TTM

0

EBITDA

-408,321,984

Profit Margin

0.00%

Return On Assets TTM

-29.16%

Return On Equity TTM

-56.65%

Revenue Per Share TTM

0.327

Qtly Revenue Growth YOY

12385.10%

Diluted Eps TTM

-2.3

Qtly Earnings Growth YOY

0.00%

Valuation

Trailing PE

0.00

Forward PE

0

Price Sales TTM

10.8206

Price Book MRQ

0

Enterprise Value Revenue

0

Enterprise Value EBITDA

0

Peers analysis

  • Nu
    0K9LNucor Corp.

    117.43

    1.45%
  • St
    0L9GState Street Corp.

    98.91

    1.33%
  • Co
    0R2XCorning Inc.

    47.81

    1.20%
  • Ex
    0IJNExelon Corp.

    37.50

    1.04%
  • Ha
    0J3HHartford Financial Services Group Inc.

    110.48

    0.92%
  • Di
    0I9FDigital Realty Trust Inc.

    179.50

    0.67%
  • Cr
    0I4WCrown Castle International Corp.

    90.95

    0.36%
  • Ge
    0R1XGeneral Mills Inc.

    63.63

    0.35%
  • Hu
    0J6ZHumana Inc.

    255.09

    0.17%
  • Pa
    0KETPaccar Inc.

    104.68

    -0.09%